1. Understand how adeno-associated viruses (AAV) are used as gene therapy vectors.
  2. Have a basic understanding of the current state-of-the art potential of AAV vectors to treat neurological diseases
  3. Have a basic understanding of the current limitations of AAV vectors to treat neurological diseases
  4. Understand how new AAV technology improvements are poised to revolutionize CNS gene therapy
Session date: 
10/14/2026 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center D1.602
Dallas, TX 75390
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.